nodes	percent_of_prediction	percent_of_DWPC	metapath
Citalopram—ABCB1—adrenal gland cancer	0.967	1	CbGaD
Citalopram—SLC6A2—sympathetic nervous system—adrenal gland cancer	0.00697	0.259	CbGeAlD
Citalopram—CYP2C19—urine—adrenal gland cancer	0.0036	0.134	CbGeAlD
Citalopram—CYP1A2—urine—adrenal gland cancer	0.00294	0.109	CbGeAlD
Citalopram—CYP2E1—urine—adrenal gland cancer	0.00264	0.0983	CbGeAlD
Citalopram—CYP3A4—urine—adrenal gland cancer	0.00213	0.0791	CbGeAlD
Citalopram—CYP2D6—urine—adrenal gland cancer	0.00209	0.0778	CbGeAlD
Citalopram—SLC6A2—gonad—adrenal gland cancer	0.000838	0.0312	CbGeAlD
Citalopram—CYP2B6—adrenal cortex—adrenal gland cancer	0.000746	0.0277	CbGeAlD
Citalopram—SLC6A2—adrenal gland—adrenal gland cancer	0.00073	0.0272	CbGeAlD
Citalopram—ADRA1A—adrenal gland—adrenal gland cancer	0.000679	0.0253	CbGeAlD
Citalopram—CYP2B6—gonad—adrenal gland cancer	0.000618	0.023	CbGeAlD
Citalopram—CYP2B6—adrenal gland—adrenal gland cancer	0.000538	0.02	CbGeAlD
Citalopram—HRH1—adrenal gland—adrenal gland cancer	0.000526	0.0196	CbGeAlD
Citalopram—CYP2E1—adrenal gland—adrenal gland cancer	0.000505	0.0188	CbGeAlD
Citalopram—ABCB1—adrenal cortex—adrenal gland cancer	0.000399	0.0148	CbGeAlD
Citalopram—ABCB1—gonad—adrenal gland cancer	0.00033	0.0123	CbGeAlD
Citalopram—ABCB1—pituitary gland—adrenal gland cancer	0.000322	0.012	CbGeAlD
Citalopram—ABCB1—adrenal gland—adrenal gland cancer	0.000288	0.0107	CbGeAlD
Citalopram—CHRM1—GPCR ligand binding—TSHR—adrenal gland cancer	2.05e-05	0.00334	CbGpPWpGaD
Citalopram—ADRA1A—GPCR ligand binding—TSHR—adrenal gland cancer	2.02e-05	0.00329	CbGpPWpGaD
Citalopram—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	1.99e-05	0.00325	CbGpPWpGaD
Citalopram—HRH1—Signaling by GPCR—GNRHR—adrenal gland cancer	1.97e-05	0.00322	CbGpPWpGaD
Citalopram—CHRM1—Signaling by GPCR—GNRHR—adrenal gland cancer	1.97e-05	0.00321	CbGpPWpGaD
Citalopram—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—adrenal gland cancer	1.97e-05	0.00321	CbGpPWpGaD
Citalopram—ADRA1A—Signaling by GPCR—GNRHR—adrenal gland cancer	1.94e-05	0.00316	CbGpPWpGaD
Citalopram—CYP2D6—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	1.91e-05	0.00311	CbGpPWpGaD
Citalopram—SLC6A3—Transmission across Chemical Synapses—BRAF—adrenal gland cancer	1.89e-05	0.00309	CbGpPWpGaD
Citalopram—CHRM1—Regulation of Actin Cytoskeleton—BRAF—adrenal gland cancer	1.88e-05	0.00307	CbGpPWpGaD
Citalopram—CYP1A2—Arachidonic acid metabolism—PTGS2—adrenal gland cancer	1.84e-05	0.003	CbGpPWpGaD
Citalopram—ADRA1A—AMPK Signaling—TP53—adrenal gland cancer	1.65e-05	0.00269	CbGpPWpGaD
Citalopram—SLC6A2—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	1.63e-05	0.00266	CbGpPWpGaD
Citalopram—CYP1A2—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	1.62e-05	0.00264	CbGpPWpGaD
Citalopram—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	1.54e-05	0.00251	CbGpPWpGaD
Citalopram—HTR2C—GPCR downstream signaling—GNRH1—adrenal gland cancer	1.5e-05	0.00245	CbGpPWpGaD
Citalopram—CYP2B6—Biological oxidations—POMC—adrenal gland cancer	1.46e-05	0.00238	CbGpPWpGaD
Citalopram—SLC6A3—Neuronal System—BRAF—adrenal gland cancer	1.45e-05	0.00237	CbGpPWpGaD
Citalopram—SLC6A3—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	1.45e-05	0.00236	CbGpPWpGaD
Citalopram—CYP2E1—Biological oxidations—POMC—adrenal gland cancer	1.43e-05	0.00233	CbGpPWpGaD
Citalopram—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—adrenal gland cancer	1.39e-05	0.00227	CbGpPWpGaD
Citalopram—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—adrenal gland cancer	1.39e-05	0.00227	CbGpPWpGaD
Citalopram—HTR2C—GPCR ligand binding—GNAS—adrenal gland cancer	1.38e-05	0.00225	CbGpPWpGaD
Citalopram—HTR2C—Signaling by GPCR—GNRH1—adrenal gland cancer	1.37e-05	0.00223	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—GNRHR—adrenal gland cancer	1.35e-05	0.0022	CbGpPWpGaD
Citalopram—HTR2C—GPCR downstream signaling—TSHR—adrenal gland cancer	1.34e-05	0.00219	CbGpPWpGaD
Citalopram—SLC6A2—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	1.32e-05	0.00216	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—SDHB—adrenal gland cancer	1.3e-05	0.00213	CbGpPWpGaD
Citalopram—HRH1—GPCR downstream signaling—GNRH1—adrenal gland cancer	1.3e-05	0.00212	CbGpPWpGaD
Citalopram—SLC6A2—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	1.3e-05	0.00212	CbGpPWpGaD
Citalopram—CHRM1—GPCR downstream signaling—GNRH1—adrenal gland cancer	1.3e-05	0.00212	CbGpPWpGaD
Citalopram—ADRA1A—GPCR downstream signaling—GNRH1—adrenal gland cancer	1.28e-05	0.00208	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—SDHB—adrenal gland cancer	1.28e-05	0.00208	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—SH3KBP1—adrenal gland cancer	1.25e-05	0.00204	CbGpPWpGaD
Citalopram—CYP3A4—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	1.25e-05	0.00203	CbGpPWpGaD
Citalopram—HTR2C—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	1.22e-05	0.00199	CbGpPWpGaD
Citalopram—HTR2C—Signaling by GPCR—TSHR—adrenal gland cancer	1.22e-05	0.00198	CbGpPWpGaD
Citalopram—HRH1—GPCR ligand binding—GNAS—adrenal gland cancer	1.2e-05	0.00195	CbGpPWpGaD
Citalopram—CHRM1—GPCR ligand binding—GNAS—adrenal gland cancer	1.19e-05	0.00194	CbGpPWpGaD
Citalopram—SLC6A4—Circadian rythm related genes—TP53—adrenal gland cancer	1.19e-05	0.00194	CbGpPWpGaD
Citalopram—HRH1—Signaling by GPCR—GNRH1—adrenal gland cancer	1.18e-05	0.00193	CbGpPWpGaD
Citalopram—CHRM1—Signaling by GPCR—GNRH1—adrenal gland cancer	1.18e-05	0.00192	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—ZNRF3—adrenal gland cancer	1.18e-05	0.00192	CbGpPWpGaD
Citalopram—SLC6A3—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	1.17e-05	0.00191	CbGpPWpGaD
Citalopram—ADRA1A—GPCR ligand binding—GNAS—adrenal gland cancer	1.17e-05	0.00191	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—GNRHR—adrenal gland cancer	1.17e-05	0.0019	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—GNRHR—adrenal gland cancer	1.16e-05	0.0019	CbGpPWpGaD
Citalopram—HRH1—GPCR downstream signaling—TSHR—adrenal gland cancer	1.16e-05	0.00189	CbGpPWpGaD
Citalopram—ADRA1A—Signaling by GPCR—GNRH1—adrenal gland cancer	1.16e-05	0.00189	CbGpPWpGaD
Citalopram—CHRM1—GPCR downstream signaling—TSHR—adrenal gland cancer	1.16e-05	0.00189	CbGpPWpGaD
Citalopram—SLC6A3—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	1.15e-05	0.00188	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—GNRHR—adrenal gland cancer	1.14e-05	0.00187	CbGpPWpGaD
Citalopram—ADRA1A—GPCR downstream signaling—TSHR—adrenal gland cancer	1.14e-05	0.00186	CbGpPWpGaD
Citalopram—CYP2C19—Biological oxidations—POMC—adrenal gland cancer	1.1e-05	0.0018	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—SH3KBP1—adrenal gland cancer	1.08e-05	0.00177	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—SH3KBP1—adrenal gland cancer	1.08e-05	0.00176	CbGpPWpGaD
Citalopram—CHRM1—Regulation of Actin Cytoskeleton—EGFR—adrenal gland cancer	1.08e-05	0.00176	CbGpPWpGaD
Citalopram—ABCB1—Integrated Pancreatic Cancer Pathway—BAD—adrenal gland cancer	1.07e-05	0.00175	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—SH3KBP1—adrenal gland cancer	1.06e-05	0.00174	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	1.06e-05	0.00173	CbGpPWpGaD
Citalopram—HRH1—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	1.06e-05	0.00172	CbGpPWpGaD
Citalopram—HRH1—Signaling by GPCR—TSHR—adrenal gland cancer	1.05e-05	0.00172	CbGpPWpGaD
Citalopram—CHRM1—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	1.05e-05	0.00172	CbGpPWpGaD
Citalopram—CHRM1—Signaling by GPCR—TSHR—adrenal gland cancer	1.05e-05	0.00171	CbGpPWpGaD
Citalopram—ADRA1A—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	1.04e-05	0.00169	CbGpPWpGaD
Citalopram—ADRA1A—Signaling by GPCR—TSHR—adrenal gland cancer	1.03e-05	0.00169	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—ZNRF3—adrenal gland cancer	1.02e-05	0.00166	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—ZNRF3—adrenal gland cancer	1.02e-05	0.00166	CbGpPWpGaD
Citalopram—CYP2D6—Biological oxidations—POMC—adrenal gland cancer	1.01e-05	0.00165	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—ZNRF3—adrenal gland cancer	1e-05	0.00163	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—SDHB—adrenal gland cancer	9.85e-06	0.00161	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—SDHB—adrenal gland cancer	9.62e-06	0.00157	CbGpPWpGaD
Citalopram—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—adrenal gland cancer	9.31e-06	0.00152	CbGpPWpGaD
Citalopram—HTR2C—GPCR ligand binding—POMC—adrenal gland cancer	9.29e-06	0.00151	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—SDHB—adrenal gland cancer	9.06e-06	0.00148	CbGpPWpGaD
Citalopram—HTR2C—Signaling by GPCR—PRKACA—adrenal gland cancer	8.73e-06	0.00142	CbGpPWpGaD
Citalopram—CYP1A2—Biological oxidations—POMC—adrenal gland cancer	8.59e-06	0.0014	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—RRM1—adrenal gland cancer	8.4e-06	0.00137	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—SDHD—adrenal gland cancer	8.4e-06	0.00137	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	8.28e-06	0.00135	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—RRM1—adrenal gland cancer	8.23e-06	0.00134	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—SDHD—adrenal gland cancer	8.23e-06	0.00134	CbGpPWpGaD
Citalopram—HTR2C—GPCR downstream signaling—CDC42—adrenal gland cancer	8.16e-06	0.00133	CbGpPWpGaD
Citalopram—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—adrenal gland cancer	8.07e-06	0.00132	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—GNRH1—adrenal gland cancer	8.07e-06	0.00132	CbGpPWpGaD
Citalopram—HRH1—GPCR ligand binding—POMC—adrenal gland cancer	8.05e-06	0.00131	CbGpPWpGaD
Citalopram—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—adrenal gland cancer	8.04e-06	0.00131	CbGpPWpGaD
Citalopram—CHRM1—GPCR ligand binding—POMC—adrenal gland cancer	8.02e-06	0.00131	CbGpPWpGaD
Citalopram—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—adrenal gland cancer	7.92e-06	0.00129	CbGpPWpGaD
Citalopram—ADRA1A—GPCR ligand binding—POMC—adrenal gland cancer	7.9e-06	0.00129	CbGpPWpGaD
Citalopram—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—adrenal gland cancer	7.89e-06	0.00129	CbGpPWpGaD
Citalopram—HTR2C—GPCR downstream signaling—GNAS—adrenal gland cancer	7.79e-06	0.00127	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	7.75e-06	0.00126	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—SDHB—adrenal gland cancer	7.68e-06	0.00125	CbGpPWpGaD
Citalopram—HRH1—Signaling by GPCR—PRKACA—adrenal gland cancer	7.57e-06	0.00123	CbGpPWpGaD
Citalopram—CHRM1—Signaling by GPCR—PRKACA—adrenal gland cancer	7.54e-06	0.00123	CbGpPWpGaD
Citalopram—ADRA1A—Signaling by GPCR—PRKACA—adrenal gland cancer	7.43e-06	0.00121	CbGpPWpGaD
Citalopram—HTR2C—Signaling by GPCR—CDC42—adrenal gland cancer	7.41e-06	0.00121	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—SPRY2—adrenal gland cancer	7.38e-06	0.0012	CbGpPWpGaD
Citalopram—ABCB1—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	7.2e-06	0.00117	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—TSHR—adrenal gland cancer	7.19e-06	0.00117	CbGpPWpGaD
Citalopram—CHRM1—Circadian rythm related genes—TP53—adrenal gland cancer	7.13e-06	0.00116	CbGpPWpGaD
Citalopram—HTR2C—Signaling by GPCR—GNAS—adrenal gland cancer	7.08e-06	0.00115	CbGpPWpGaD
Citalopram—HRH1—GPCR downstream signaling—CDC42—adrenal gland cancer	7.07e-06	0.00115	CbGpPWpGaD
Citalopram—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—adrenal gland cancer	7.06e-06	0.00115	CbGpPWpGaD
Citalopram—CHRM1—GPCR downstream signaling—CDC42—adrenal gland cancer	7.05e-06	0.00115	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—GNRH1—adrenal gland cancer	6.99e-06	0.00114	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—GNRH1—adrenal gland cancer	6.97e-06	0.00114	CbGpPWpGaD
Citalopram—ADRA1A—GPCR downstream signaling—CDC42—adrenal gland cancer	6.94e-06	0.00113	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—GNRH1—adrenal gland cancer	6.86e-06	0.00112	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—MEN1—adrenal gland cancer	6.76e-06	0.0011	CbGpPWpGaD
Citalopram—HRH1—GPCR downstream signaling—GNAS—adrenal gland cancer	6.75e-06	0.0011	CbGpPWpGaD
Citalopram—CHRM1—GPCR downstream signaling—GNAS—adrenal gland cancer	6.73e-06	0.0011	CbGpPWpGaD
Citalopram—ADRA1A—GPCR downstream signaling—GNAS—adrenal gland cancer	6.63e-06	0.00108	CbGpPWpGaD
Citalopram—CYP3A4—Biological oxidations—POMC—adrenal gland cancer	6.63e-06	0.00108	CbGpPWpGaD
Citalopram—HRH1—Signaling by GPCR—CDC42—adrenal gland cancer	6.42e-06	0.00105	CbGpPWpGaD
Citalopram—CHRM1—Signaling by GPCR—CDC42—adrenal gland cancer	6.4e-06	0.00104	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—SPRY2—adrenal gland cancer	6.39e-06	0.00104	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—SPRY2—adrenal gland cancer	6.37e-06	0.00104	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—SDHD—adrenal gland cancer	6.35e-06	0.00104	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—RRM1—adrenal gland cancer	6.35e-06	0.00104	CbGpPWpGaD
Citalopram—ADRA1A—Signaling by GPCR—CDC42—adrenal gland cancer	6.3e-06	0.00103	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—SPRY2—adrenal gland cancer	6.27e-06	0.00102	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—MED12—adrenal gland cancer	6.26e-06	0.00102	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—TSHR—adrenal gland cancer	6.23e-06	0.00102	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—TSHR—adrenal gland cancer	6.21e-06	0.00101	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—RRM1—adrenal gland cancer	6.2e-06	0.00101	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—SDHD—adrenal gland cancer	6.2e-06	0.00101	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—MED12—adrenal gland cancer	6.14e-06	0.001	CbGpPWpGaD
Citalopram—HRH1—Signaling by GPCR—GNAS—adrenal gland cancer	6.13e-06	0.001	CbGpPWpGaD
Citalopram—CHRM1—Signaling by GPCR—GNAS—adrenal gland cancer	6.11e-06	0.000997	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—TSHR—adrenal gland cancer	6.11e-06	0.000997	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	6.04e-06	0.000985	CbGpPWpGaD
Citalopram—ADRA1A—Signaling by GPCR—GNAS—adrenal gland cancer	6.02e-06	0.000981	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—SDHB—adrenal gland cancer	5.92e-06	0.000966	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—MEN1—adrenal gland cancer	5.86e-06	0.000955	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—RRM1—adrenal gland cancer	5.84e-06	0.000952	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—SDHD—adrenal gland cancer	5.84e-06	0.000952	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—MEN1—adrenal gland cancer	5.84e-06	0.000952	CbGpPWpGaD
Citalopram—ABCB1—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	5.83e-06	0.000951	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—MEN1—adrenal gland cancer	5.75e-06	0.000937	CbGpPWpGaD
Citalopram—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—adrenal gland cancer	5.59e-06	0.000912	CbGpPWpGaD
Citalopram—HTR2C—GPCR downstream signaling—POMC—adrenal gland cancer	5.25e-06	0.000856	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—PRKACA—adrenal gland cancer	5.16e-06	0.000841	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—RRM1—adrenal gland cancer	4.95e-06	0.000807	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—SDHD—adrenal gland cancer	4.95e-06	0.000807	CbGpPWpGaD
Citalopram—HTR2C—Signaling by GPCR—POMC—adrenal gland cancer	4.77e-06	0.000777	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—MED12—adrenal gland cancer	4.73e-06	0.000772	CbGpPWpGaD
Citalopram—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—adrenal gland cancer	4.7e-06	0.000766	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—MED12—adrenal gland cancer	4.62e-06	0.000753	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—PRKACA—adrenal gland cancer	4.57e-06	0.000745	CbGpPWpGaD
Citalopram—HRH1—GPCR downstream signaling—POMC—adrenal gland cancer	4.55e-06	0.000742	CbGpPWpGaD
Citalopram—CHRM1—GPCR downstream signaling—POMC—adrenal gland cancer	4.53e-06	0.000739	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—PRKACA—adrenal gland cancer	4.48e-06	0.00073	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—PRKACA—adrenal gland cancer	4.47e-06	0.000729	CbGpPWpGaD
Citalopram—ADRA1A—GPCR downstream signaling—POMC—adrenal gland cancer	4.46e-06	0.000728	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—PRKACA—adrenal gland cancer	4.46e-06	0.000727	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—PRKACA—adrenal gland cancer	4.39e-06	0.000715	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—CDC42—adrenal gland cancer	4.38e-06	0.000714	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—MED12—adrenal gland cancer	4.35e-06	0.00071	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	4.23e-06	0.00069	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—IGF2—adrenal gland cancer	4.22e-06	0.000688	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—GNAS—adrenal gland cancer	4.18e-06	0.000682	CbGpPWpGaD
Citalopram—HRH1—Signaling by GPCR—POMC—adrenal gland cancer	4.13e-06	0.000673	CbGpPWpGaD
Citalopram—CHRM1—Signaling by GPCR—POMC—adrenal gland cancer	4.12e-06	0.000671	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—IGF1R—adrenal gland cancer	4.08e-06	0.000665	CbGpPWpGaD
Citalopram—ADRA1A—Signaling by GPCR—POMC—adrenal gland cancer	4.05e-06	0.000661	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—RRM1—adrenal gland cancer	3.82e-06	0.000623	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—SDHD—adrenal gland cancer	3.82e-06	0.000623	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—CDC42—adrenal gland cancer	3.79e-06	0.000618	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—CDC42—adrenal gland cancer	3.78e-06	0.000616	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—CDC42—adrenal gland cancer	3.72e-06	0.000607	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—GNAS—adrenal gland cancer	3.7e-06	0.000604	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—MED12—adrenal gland cancer	3.69e-06	0.000601	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—IGF2—adrenal gland cancer	3.65e-06	0.000596	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—IGF2—adrenal gland cancer	3.64e-06	0.000594	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—ABCB1—adrenal gland cancer	3.63e-06	0.000593	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—GNAS—adrenal gland cancer	3.63e-06	0.000592	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—GNAS—adrenal gland cancer	3.62e-06	0.000591	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—GNAS—adrenal gland cancer	3.61e-06	0.000589	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—IGF2—adrenal gland cancer	3.59e-06	0.000585	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—ABCB1—adrenal gland cancer	3.56e-06	0.00058	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—GNAS—adrenal gland cancer	3.56e-06	0.00058	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—IGF1R—adrenal gland cancer	3.53e-06	0.000576	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—IGF1R—adrenal gland cancer	3.52e-06	0.000574	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—TERT—adrenal gland cancer	3.51e-06	0.000572	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—IGF1R—adrenal gland cancer	3.47e-06	0.000565	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—PRKACA—adrenal gland cancer	3.45e-06	0.000563	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	3.38e-06	0.00055	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—PRKACA—adrenal gland cancer	3.37e-06	0.00055	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	3.3e-06	0.000538	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—PRKACA—adrenal gland cancer	3.18e-06	0.000518	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—BAD—adrenal gland cancer	3.05e-06	0.000498	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—TERT—adrenal gland cancer	3.04e-06	0.000496	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—TERT—adrenal gland cancer	3.03e-06	0.000494	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—TERT—adrenal gland cancer	2.98e-06	0.000487	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—MED12—adrenal gland cancer	2.85e-06	0.000464	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—POMC—adrenal gland cancer	2.82e-06	0.000459	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—GNAS—adrenal gland cancer	2.8e-06	0.000456	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—BRAF—adrenal gland cancer	2.78e-06	0.000453	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—ABCB1—adrenal gland cancer	2.75e-06	0.000448	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—GNAS—adrenal gland cancer	2.73e-06	0.000445	CbGpPWpGaD
Citalopram—HTR2C—Signaling by GPCR—EGFR—adrenal gland cancer	2.69e-06	0.000439	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—PRKACA—adrenal gland cancer	2.69e-06	0.000439	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—BAD—adrenal gland cancer	2.65e-06	0.000432	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—BAD—adrenal gland cancer	2.64e-06	0.00043	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	2.63e-06	0.000429	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—BAD—adrenal gland cancer	2.6e-06	0.000423	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—GNAS—adrenal gland cancer	2.57e-06	0.00042	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—ABCB1—adrenal gland cancer	2.53e-06	0.000412	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—POMC—adrenal gland cancer	2.49e-06	0.000407	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—POMC—adrenal gland cancer	2.44e-06	0.000398	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—POMC—adrenal gland cancer	2.44e-06	0.000398	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—POMC—adrenal gland cancer	2.43e-06	0.000397	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—BRAF—adrenal gland cancer	2.41e-06	0.000393	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—BRAF—adrenal gland cancer	2.4e-06	0.000392	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—POMC—adrenal gland cancer	2.39e-06	0.00039	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—BRAF—adrenal gland cancer	2.36e-06	0.000385	CbGpPWpGaD
Citalopram—HRH1—Signaling by GPCR—EGFR—adrenal gland cancer	2.33e-06	0.000381	CbGpPWpGaD
Citalopram—CHRM1—Signaling by GPCR—EGFR—adrenal gland cancer	2.33e-06	0.00038	CbGpPWpGaD
Citalopram—ADRA1A—Signaling by GPCR—EGFR—adrenal gland cancer	2.29e-06	0.000374	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—GNAS—adrenal gland cancer	2.18e-06	0.000356	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—ABCB1—adrenal gland cancer	2.14e-06	0.000349	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—PRKACA—adrenal gland cancer	2.08e-06	0.000339	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—CTNNB1—adrenal gland cancer	2.01e-06	0.000328	CbGpPWpGaD
Citalopram—CYP2B6—Metabolism—PTGS2—adrenal gland cancer	1.99e-06	0.000324	CbGpPWpGaD
Citalopram—CYP2E1—Metabolism—PTGS2—adrenal gland cancer	1.95e-06	0.000318	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—POMC—adrenal gland cancer	1.88e-06	0.000307	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—POMC—adrenal gland cancer	1.84e-06	0.0003	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—CTNNB1—adrenal gland cancer	1.74e-06	0.000284	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—CTNNB1—adrenal gland cancer	1.74e-06	0.000283	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—POMC—adrenal gland cancer	1.73e-06	0.000283	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—CTNNB1—adrenal gland cancer	1.71e-06	0.000279	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—GNAS—adrenal gland cancer	1.68e-06	0.000274	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—ABCB1—adrenal gland cancer	1.65e-06	0.000269	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—EGFR—adrenal gland cancer	1.59e-06	0.00026	CbGpPWpGaD
Citalopram—CYP2C19—Metabolism—PTGS2—adrenal gland cancer	1.5e-06	0.000245	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—POMC—adrenal gland cancer	1.47e-06	0.000239	CbGpPWpGaD
Citalopram—ABCB1—Metabolism—PTGS2—adrenal gland cancer	1.47e-06	0.000239	CbGpPWpGaD
Citalopram—CYP2D6—Metabolism—PTGS2—adrenal gland cancer	1.38e-06	0.000225	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—EGFR—adrenal gland cancer	1.38e-06	0.000225	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—EGFR—adrenal gland cancer	1.37e-06	0.000224	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—EGFR—adrenal gland cancer	1.35e-06	0.000221	CbGpPWpGaD
Citalopram—HTR2C—Signaling Pathways—TP53—adrenal gland cancer	1.34e-06	0.000218	CbGpPWpGaD
Citalopram—CYP1A2—Metabolism—PTGS2—adrenal gland cancer	1.17e-06	0.000191	CbGpPWpGaD
Citalopram—HRH1—Signaling Pathways—TP53—adrenal gland cancer	1.16e-06	0.000189	CbGpPWpGaD
Citalopram—CHRM1—Signaling Pathways—TP53—adrenal gland cancer	1.15e-06	0.000188	CbGpPWpGaD
Citalopram—ADRA1A—Signaling Pathways—TP53—adrenal gland cancer	1.14e-06	0.000185	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—POMC—adrenal gland cancer	1.13e-06	0.000185	CbGpPWpGaD
Citalopram—CYP3A4—Metabolism—PTGS2—adrenal gland cancer	9.04e-07	0.000147	CbGpPWpGaD
